Go from a hunch to informed decisions.
Take any idea and uncover the companies, evidence, and rules behind it. Inspect its performance and compare it with a benchmark.
Research an idea, invest through your brokerage, and get portfolio reviews that come back to you—all in one conversation.
Take any idea and uncover the companies, evidence, and rules behind it. Inspect its performance and compare it with a benchmark.
Turn any theme into a trade proposal for your connected accounts. Review the allocation and orders before you commit. We do the research. You approve
Preparing your investment proposal…
Prepared orders for your review
Trade proposal
IBKR · Individual
No order has been placed yet. Review and confirm before submitting.
Schedule a portfolio review and choose when you want to hear back. Tilt checks your targets and pings you when your attention is needed.
Weekly review scheduled
Monday · 9:00 AM · America/New_York
Monday, 9:00 AM
Your $5,000 purchase of AI Biotech Tools and Infrastructure came out of cash, so two things need your attention against your saved targets.
Trimming VTI would restore your cash buffer. Want to look at the allocation in more detail?
Understand what moved across your accounts, why it happened, and how it connects to your investment decisions.
Looked up tickers, ran 4 commands, read 2 files
Your call on core CPI is paying off. August core inflation came in at 2.4% year over year, below the 3% threshold in your inflation contract.
Headline inflation was higher, at 3.4%, strengthening expectations of a Fed rate hike. That also matters for your rate-decision position:
U.S. inflation stayed stubbornly high in August, bolstering the case for the Federal Reserve to raise interest rates at its meeting next week. The New York Times
Your event-contract portfolio is up $126 over its available history, after fees.
Event Contracts · YTD requested · Showing available history Jul 21-Oct 2, 2026
Net Change
$126Return
+4.20%Fees
$18You also added $5,000 to AI Biotech Tools and Infrastructure, including Illumina, Thermo Fisher, and Agilent. That is a new allocation, separate from the gains in your event contracts.